Fengcai Zhu

23PUBLICATIONS
29CO-AUTHORS
Pacific Peoples theory of change models for healthPacific Peoples epidemiologyInfant and child healthInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 27, 2025
Effectiveness of a booster dose of aerosolized or intramuscular adenovirus type 5 vectored COVID-19 vaccine in adults: a multicenter, partially randomized, platform trial in China.

Siyue Jia, Yuanbao Liu, Qian He

|Feb 07, 2025
Immunogenicity and safety of a live attenuated varicella vaccine in healthy subjects aged between 13 to 55 years: a double-blind, randomized, active-controlled phase III clinical trial in China.

Yang Zhang, Shiyuan Wang, Guifan Li

|Feb 03, 2025
Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China.

Shiyuan Wang, Yang Zhang, Guifan Li

|Jan 27, 2025
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial.

Siyue Jia, Chengwei Shao, Xin Cheng

|Nov 21, 2024
AS03-adjuvanted H5N1 vaccine enhances immune response by modulating NR4A1, SDC1, ID3 genes, and reducing cortisol.

Lairun Jin, Jingxin Li, Fengcai Zhu

|Nov 11, 2024
Immunogenicity and safety of two-dose or three-dose regimens of inactivated COVID-19 vaccines in patients with pulmonary tuberculosis: a randomised clinical trial.

Pengfei Jin, Qiao Liu, Wenli Chen

Pageof 4

Frequent Collaborators

2 joint publications

Kang Wang

2 joint publications

Ling Zhu

2 joint publications

Jingxin Li

2 joint publications

Lunbiao Cui